Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
Elena Yeregui(Institut de Recerca Biomèdica Catalunya Sud), Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Verònica Alba, Anna Martí(Institut de Recerca Biomèdica Catalunya Sud), Yolanda M. Pacheco(Instituto de Biomedicina de Sevilla), María Peraire(Hospital Universitario Son Espases), Manuel Leal(Apple (Israel)), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Jenifer Masip(Hospital Universitari Joan XXIII de Tarragona), Judit Vidal‐González(Vall d'Hebron Institut de Recerca), Josep Mallolas(Hospital Clínic de Barcelona), Laia Reverté(Institute for Research and Technology in Food and Agriculture), Fréderic Gómez-Bertomeu, Peré Domingo(Hospital de Sant Pau), Montserrat Olona, Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Julià Blanco(IrsiCaixa), Montserrat Vargas(Hospital Universitari Joan XXIII de Tarragona), Graciano García‐Pardo(Instituto de Salud Carlos III), Joaquim Peraire(Instituto de Salud Carlos III), Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya)
Cited by 10
Related Papers
Ultraviolet vision in lizards
|Nature|1993|257
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
|The EMBO Journal|2002|147
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143